Mutagenic deaminase activity in cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110239
- Recipient
-
The Washington University UEI L6NFUM28LQM5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,260,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- University City, MO 63130, USA
Award details come from USAspending.gov.
About this award
The Washington University will receive $1,260,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on mutagenic deaminase activity in cancer from September 2021 through September 2025.
Through this four-year project grant award, The Washington University researchers in University City, Missouri will investigate mutagenic deaminase activity and its relationship to cancer development and progression. The Military Medical Research and Development program supports biomedical research that transforms military and public health care by developing medical solutions for battlefield injuries and investigating innovative approaches to cancer and other diseases. The outcomes of this research could provide insights into new therapeutic strategies for treating cancer.
Quick answers
Who received award W81XWH2110239?
W81XWH2110239 was awarded to The Washington University by Medical Command (Department of the Army) on September 15, 2021.
How much is award W81XWH2110239 worth?
$1,260,000 has been obligated on W81XWH2110239.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award